Cancer Risk clinical trials at UCSF
1 research study open to eligible people
Cancer risk is how likely someone is to get cancer. UCSF is enrolling people at higher risk to receive extra MRI screening alongside mammography. Scientists compare cancer detection rates from MRI and usual screening methods.
Showing trials for
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
open to eligible females ages 40-89
This is a multi-center, single arm trial to evaluate the cancer detection rate of supplemental screening magnetic resonance imaging (MRI) in participants who are high-risk by Mirai-MRI assessment. Mirai is an accurate cancer risk model based on full-resolution mammograms.
San Francisco, California and other locations
Our lead scientists for Cancer Risk research studies include Maggie Chung, MD.
Last updated: